FC
CLDI.WS
Finepoint Capital’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-655,200
| Closed | -$8.58K | – | 31 |
|
|
2024
Q3 | $8.58K | Hold |
655,200
| – | – | ﹤0.01% | 24 |
|
|
2024
Q2 | $27.6K | Hold |
655,200
| – | – | 0.01% | 22 |
|
|
2024
Q1 | $34.1K | Hold |
655,200
| – | – | 0.01% | 23 |
|
|
2023
Q4 | $32.8K | Hold |
655,200
| – | – | 0.01% | 21 |
|
|
2023
Q3 | $144K | Hold |
655,200
| – | – | 0.07% | 21 |
|
|
2023
Q2 | $85.2K | Hold |
655,200
| – | – | 0.03% | 25 |
|
|
2023
Q1 | $26.9K | Hold |
655,200
| – | – | 0.01% | 36 |
|
|
2022
Q4 | $33K | Hold |
655,200
| – | – | 0.01% | 33 |
|
|
2022
Q3 | $37K | Hold |
655,200
| – | – | 0.01% | 39 |
|
|
2022
Q2 | $59K | Hold |
655,200
| – | – | 0.02% | 50 |
|
|
2022
Q1 | $236K | Hold |
655,200
| – | – | 0.08% | 39 |
|
|
2021
Q4 | $328K | Buy |
+655,200
| New | +$328K | 0.08% | 56 |
|